当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析 - 现金流量表

荣昌生物

(688331)

  

流通市值:110.94亿  总市值:385.45亿
流通股本:1.62亿   总股本:5.64亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金475,062,495.731,496,544,541.191,097,729,076.75578,872,361.56
收到的税费返还1,051,545.2214,123,058.4414,112,207.5114,112,207.51
收到其他与经营活动有关的现金3,885,843.42121,832,252.34110,331,330.1140,621,916.79
经营活动现金流入的平衡项目0000
经营活动现金流入小计479,999,884.371,632,499,851.971,222,172,614.37633,606,485.86
购买商品、接受劳务支付的现金13,281,935.21143,134,491.15103,969,884.3391,739,118.95
支付给职工以及为职工支付的现金280,175,888.451,085,094,453.63837,884,001.41561,880,136.3
支付的各项税费41,460,861.0674,347,927.9837,431,526.6225,128,866.66
支付其他与经营活动有关的现金333,396,332.731,444,226,492.411,077,990,268.89775,027,901.27
经营活动现金流出的平衡项目0000
经营活动现金流出小计668,315,017.452,746,803,365.172,057,275,681.251,453,776,023.18
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-188,315,133.08-1,114,303,513.2-835,103,066.88-820,169,537.32
二、投资活动产生的现金流量:
收回投资收到的现金150,000,0001,000,000,000520,078,626.05-
取得投资收益收到的现金177,6252,601,249.991,360,416.66-
处置固定资产、无形资产和其他长期资产收回的现金净额95,0007,201,197.615,461,797.612,434.04
收到的其他与投资活动有关的现金9,578,40013,994,347.4413,994,347.4413,994,347.44
投资活动现金流入的平衡项目0000
投资活动现金流入小计159,851,0251,023,796,795.04540,895,187.7613,996,781.48
购建固定资产、无形资产和其他长期资产支付的现金35,638,909.83265,281,866.7179,951,645.19141,800,894.58
投资支付的现金151,000,0001,006,750,000786,750,000206,750,000
支付其他与投资活动有关的现金---16,893.66
投资活动现金流出的平衡项目0000
投资活动现金流出小计186,638,909.831,272,031,866.7966,701,645.19348,567,788.24
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-26,787,884.83-248,235,071.66-425,806,457.43-334,571,006.76
三、筹资活动产生的现金流量:
吸收投资收到的现金232,945.361,032,897.911,032,897.911,032,897.91
取得借款收到的现金530,463,578.441,804,572,341.411,315,592,447.571,175,612,956.06
筹资活动现金流入平衡项目0000
筹资活动现金流入小计530,696,523.81,805,605,239.321,316,625,345.481,176,645,853.97
偿还债务支付的现金316,006,600.73257,688,039.441,569,400633,000
分配股利、利润或偿付利息支付的现金23,994,702.4269,826,300.8453,218,519.4529,783,088.54
支付其他与筹资活动有关的现金13,971,255.6285,122,094.9659,778,979.1946,734,249.23
筹资活动现金流出平衡项目0000
筹资活动现金流出小计353,972,558.77412,636,435.24114,566,898.6477,150,337.77
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额176,723,965.031,392,968,804.081,202,058,446.841,099,495,516.2
四、汇率变动对现金及现金等价物的影响-2,367,997.432,547,892.84-5,694,629.931,835,202.01
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-40,747,050.3132,978,112.06-64,545,707.4-53,409,825.87
加:期初现金及现金等价物余额759,530,043.42726,551,931.36726,551,931.36726,551,931.36
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额718,782,993.11759,530,043.42662,006,223.96673,142,105.49
补充资料:
净利润--1,468,360,802.55--780,459,767.69
资产减值准备-9,555,364.02-9,549,077.11
固定资产和投资性房地产折旧-228,508,218.18-108,370,610.93
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-228,508,218.18-108,370,610.93
无形资产摊销-7,538,995.87-3,679,523.23
长期待摊费用摊销-5,584,443.58-1,984,026.7
待摊费用的减少-1,184,445.13--
处置固定资产、无形资产和其他长期资产的损失-704,096.08--
固定资产报废损失-225,093.39-97,754.85
公允价值变动损失--1,537,475.88--595,107.65
财务费用-71,281,059.57-32,439,015.51
投资损失--2,404,171.3-105,092.84
存货的减少-72,384,239.6--9,319,742.74
经营性应收项目的减少--333,326,264.25--200,781,882.73
经营性应付项目的增加-152,463,841.12--56,510,067.98
其他---37,057,697.72
现金的期末余额-759,530,043.42-673,142,105.49
减:现金的期初余额-726,551,931.36-726,551,931.36
公告日期2025-04-292025-03-282024-10-302024-08-17
审计意见(境内)标准无保留意见
TOP↑